UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q
[ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
For the fiscal quarter ended: July 31, 2011
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period ended: ________________________
If the notification relates to a portion of the filing checked above,
indentiy the Item(s) to which the notification relates:
---------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
Biosynergy, Inc.
(Full Name of Registrant)
N/A
(Former Name if Applicable)
1940 East Devon Avenue
(Address of Principal Executive Office (Street and Number))
Elk Grove Village, Illinois 60007
(City, State and Zip Code)
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
(a) The reason described in reasonable detail in Part II of this form
could not be eliminated without unreasonable effort or expense
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly report or
transition report on Form 10-Q or subject distribution report on Form
10-D, or portion thereof, will be filed on or before the fifth calendar
day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q 10-D,
N-SAR, N-CSR, or the transition report or portion thereof, could not be
filed within the prescribed time period.
A test filing of the above referenced Form 10-Q was filed on September
14, 2011 prior to the deadline at 4:18 p.m. (5:18 p.m. Eastern Time)
as evidenced by Accession Number: 0000715812-11-000004. Unfortunately,
a correction to the labeling of one of the exhibits needed to be made
and while making this correction, the Registrant's counsel's unfamiliarity
with the new XBRL Filing format required by the SEC combined with a
computer problem caused the live filing to be made at 5:00 p.m. (6:00 p.m.
Eastern Time).
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification
Lauane C. Addis (312) 377-7853
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for
such shorter period that the registrant was required to file such
report(s) been filed? If answer is no, identify report(s).
Yes [X] No [ ]
(3) Is it anticipated that any significant change in results of
operation from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in
the subject report or portion thereof?
Yes [ ] No [X]
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
-----------------------------------------------------------------------
Biosynergy, Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 15, 2011 By: /Lauane C. Addis/
------------------------
Attorney for Registrant